Join
Live feed
·
PRReleasevia Quantisnow
AcelRx Pharmaceuticals Inc. logo
Anika Therapeutics Inc. logo
Axogen Inc. logo
+5

TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues

ByQuantisnow·Wall Street's wire, on your screen.
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues | Quantisnow